Clinical Trials Logo

Prediabetic State clinical trials

View clinical trials related to Prediabetic State.

Filter by:

NCT ID: NCT01411540 Completed - Obesity Clinical Trials

Effects of a Wholegrain Diet on Body Composition and Energy Balance

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to compare a diet containing whole grains versus an energy matched diet using refined grains on body composition and metabolism.

NCT ID: NCT01386645 Completed - Prediabetes Clinical Trials

Effect of Dietary Glycemic Index on Beta-cell Function

GIdiet
Start date: July 2011
Phase: N/A
Study type: Interventional

The study will determine if increasing the highs and lows of blood glucose levels (glycemic variability) impairs insulin secretion in people with impaired glucose tolerance and/or impaired fasting glucose who are at risk for developing type 2 diabetes. Furthermore, the study will determine whether changes in beta-cell function are associated with glycemic variability and whether they are mediated by oxidative stress. To decrease or increase glycemic variability the study will provide subjects with special diets containing either low or high glycemic index foods respectively for 4 weeks. To determine if oxidative stress is a mediator, subjects on the high glycemic index diet will take either placebo or the anti-oxidant N-acetylcysteine. The study will address the hypothesis that increased glycemic variability results in increased oxidative stress and thereby exacerbates beta-cell dysfunction in individuals with impaired glucose tolerance and/or impaired fasting glucose. The findings may have important implications for the development of effective strategies aimed at the prevention and treatment of type 2 diabetes. In addition, understanding the contribution of dietary glycemic index to beta-cell dysfunction in subjects with pre-diabetes may have a significant public health impact, including changes to dietary counseling and promotion of healthier eating patterns.

NCT ID: NCT01385865 Completed - Prediabetic State Clinical Trials

Effect of Mulberry Leaf Extract on Blood Glucose

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose in subjects with impaired fasting glucose.

NCT ID: NCT01371266 Completed - Pre-diabetes Clinical Trials

Glycemic Effects of Honey

Start date: June 2011
Phase: N/A
Study type: Interventional

Honey has been used as a sweetener for centuries. Recent data indicate that honey consumption may have beneficial effects upon glucose intolerance, a health issue currently affecting 57 million Americans of every age and ethnicity. In order to evaluate the glycemic effect of honey, the investigators will carry out a human trial assessing biomarkers of blood glucose responses, insulin sensitivity, oxidative stress, and inflammatory markers. Our primary objective is to determine the glycemic effects of honey in comparison to sucrose and high fructose corn syrup (HFCS). The investigators hypothesize that honey will promote improved glucose tolerance and insulin sensitivity compared to both sucrose and high fructose corn syrup in normal glycemic and glucose intolerant adults.

NCT ID: NCT01365013 Completed - Prediabetic State Clinical Trials

Evaluation of the Translation of the DE-PLAN Program for the Primary Prevention of Type 2 Diabetes in Routine Primary Care

DE-PLAN E
Start date: June 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the feasibility and effectiveness of the DE-PLAN Euskadi program for the primary prevention of type-II diabetes in high-risk population seen in primary care centers (Osakidetza-Basque Health Service) in which such intervention is implemented, compared to usual care control centers.

NCT ID: NCT01346254 Completed - Clinical trials for Kidney Transplantation

Glucose Control in Pre-Diabetic Renal Transplant Patients

GCPD
Start date: December 2009
Phase: Phase 2
Study type: Interventional

Development of New-Onset Diabetes after Transplantation (NODAT) is common and serious complication after kidney transplantation. Patients who develop NODAT are at increased risk for loss of the transplanted organ and for diseases of the cardiovascular system. It is believed that in many patients the development of overt NODAT is preceded by a phase of impaired glucose tolerance that is called pre-diabetes. This study aims at improving glucose metabolism in patients after kidney transplantation who are in a pre-diabetic metabolic state. Patients who exhibit impaired glucose tolerance (IGT) after kidney transplantation are randomized to either receive vildagliptin (Galvus), pioglitazone(Actos) or placebo for three months. The investigators hypothesize that treatment with vildagliptin or pioglitazone leads to improved glycemic control compared to placebo.

NCT ID: NCT01336322 Completed - Pre-diabetes Clinical Trials

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

Start date: May 2011
Phase: Phase 2
Study type: Interventional

The goal of the present research is to compare the effects of treatment with metformin and sitagliptin, alone or in association, in women with previous gestational diabetes to evaluate the impact of the two drugs on beta-cell function. The study results may contribute to give a rational approach for future investigations.

NCT ID: NCT01326533 Completed - Pre-diabetes Clinical Trials

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

Start date: March 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the short-term effects of the antimalarial medication, hydroxychloroquine (HCQ), compared with placebo using frequently sampled intravenous glucose tolerance testing (FSIGTT) methodology to study changes in insulin secretion and glucose tolerance in subjects at risk for developing Type 2 diabetes.

NCT ID: NCT01301521 Completed - Diabetes Clinical Trials

Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics

Cinnamon
Start date: June 11, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether water-soluble cinnamon extract plus aggressive lifestyle intervention is effective in lowering blood glucose in pre-diabetic patients when compared to aggressive lifestyle therapy plus placebo.

NCT ID: NCT01301339 Completed - Diabetes Clinical Trials

A1c FIT TEST: An Epidemiological Study Correlating Hemoglobin A1c With Results of the Air Force Physical FITness TEST.

Start date: July 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the prevalence of pre-diabetes and diabetes among those Air Force personnel who have not passed the Air Force physical fitness test (AFPT) and to evaluate the usefulness of the AFPT as a prescreening tool for these disease processes.